Sand Hill Global Advisors LLC Purchases 251 Shares of Stryker Co. (NYSE:SYK)

Sand Hill Global Advisors LLC raised its holdings in shares of Stryker Co. (NYSE:SYK) by 1.0% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 26,495 shares of the medical technology company’s stock after acquiring an additional 251 shares during the period. Sand Hill Global Advisors LLC’s holdings in Stryker were worth $7,934,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in SYK. Bremer Bank National Association boosted its holdings in shares of Stryker by 4.0% during the fourth quarter. Bremer Bank National Association now owns 888 shares of the medical technology company’s stock worth $266,000 after purchasing an additional 34 shares during the period. Simon Quick Advisors LLC boosted its holdings in shares of Stryker by 3.0% during the fourth quarter. Simon Quick Advisors LLC now owns 1,158 shares of the medical technology company’s stock worth $347,000 after purchasing an additional 34 shares during the period. Consolidated Portfolio Review Corp boosted its holdings in shares of Stryker by 3.6% during the fourth quarter. Consolidated Portfolio Review Corp now owns 983 shares of the medical technology company’s stock worth $294,000 after purchasing an additional 34 shares during the period. FourThought Financial Partners LLC boosted its holdings in shares of Stryker by 3.3% during the fourth quarter. FourThought Financial Partners LLC now owns 1,076 shares of the medical technology company’s stock worth $322,000 after purchasing an additional 34 shares during the period. Finally, Catalyst Financial Partners LLC boosted its holdings in shares of Stryker by 3.0% during the fourth quarter. Catalyst Financial Partners LLC now owns 1,154 shares of the medical technology company’s stock worth $346,000 after purchasing an additional 34 shares during the period. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have commented on SYK. Piper Sandler raised their price objective on shares of Stryker from $375.00 to $380.00 and gave the stock an “overweight” rating in a report on Wednesday, May 1st. UBS Group raised their price objective on shares of Stryker from $339.00 to $351.00 and gave the stock a “neutral” rating in a report on Wednesday, May 1st. Roth Mkm raised their price objective on shares of Stryker from $348.00 to $405.00 and gave the stock a “buy” rating in a report on Wednesday, May 1st. Royal Bank of Canada raised their price objective on shares of Stryker from $360.00 to $386.00 and gave the stock an “outperform” rating in a report on Monday, April 15th. Finally, Needham & Company LLC upgraded shares of Stryker from a “hold” rating to a “buy” rating and set a $392.00 price objective for the company in a report on Wednesday. Three research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $367.32.

Insider Transactions at Stryker

In other news, CAO William E. Berry, Jr. sold 7,690 shares of Stryker stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $358.48, for a total transaction of $2,756,711.20. Following the transaction, the chief accounting officer now owns 3,675 shares in the company, valued at approximately $1,317,414. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 5.50% of the company’s stock.

Stryker Stock Performance

SYK stock traded up $4.91 on Wednesday, hitting $335.42. The company had a trading volume of 1,611,447 shares, compared to its average volume of 1,336,249. Stryker Co. has a 12-month low of $249.98 and a 12-month high of $361.41. The company has a current ratio of 1.71, a quick ratio of 0.99 and a debt-to-equity ratio of 0.56. The stock’s 50-day simple moving average is $341.13 and its 200 day simple moving average is $323.29. The stock has a market cap of $127.78 billion, a price-to-earnings ratio of 37.73, a P/E/G ratio of 2.57 and a beta of 0.91.

Stryker (NYSE:SYK) last issued its earnings results on Tuesday, April 30th. The medical technology company reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.36 by $0.14. Stryker had a net margin of 16.03% and a return on equity of 23.05%. The company had revenue of $5.24 billion for the quarter, compared to analysts’ expectations of $5.10 billion. During the same quarter last year, the company posted $2.14 earnings per share. The firm’s quarterly revenue was up 9.7% on a year-over-year basis. As a group, equities research analysts expect that Stryker Co. will post 11.94 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 31st. Stockholders of record on Friday, June 28th will be paid a dividend of $0.80 per share. This represents a $3.20 annualized dividend and a dividend yield of 0.95%. The ex-dividend date is Friday, June 28th. Stryker’s dividend payout ratio is presently 36.53%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.